Overview

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

Status:
Enrolling by invitation
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of 1% Pro-ocular topical gel administered twice daily for 12 weeks in treatment of Dry Eye Disease
Phase:
Phase 2
Details
Lead Sponsor:
PharmaDax Inc.
Collaborator:
Glia, LLC